Giuseppe Visani

Pesaro, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

Clarkson disease in critically and non-critically ill patients: insights from the Italian IRIS-CLS registry.

Clarkson disease in critically and non-critically ill patients: insights from the Italian IRIS-CLS registry.

Journal: Internal and emergency medicine
Published: October 01, 2024

Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche.

Hematopoietic and leukemic stem cells homeostasis: the role of bone marrow niche.

Journal: Exploration of targeted anti-tumor therapy
Published: March 23, 2024

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy.

Journal: Haematologica
Published: March 15, 2024

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.

Journal: Clinical lymphoma, myeloma & leukemia
Published: November 14, 2023

Fms -like tyrosine kinase 3 positive acute myeloid leukemia.

Fms -like tyrosine kinase 3 positive acute myeloid leukemia.

Journal: Current opinion in oncology
Published: October 11, 2023

Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT.

Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT.

Journal: HemaSphere
Published: February 14, 2023

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis.

Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis.

Journal: Cancers
Published: February 02, 2023

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.

Journal: Hematological oncology
Published: August 13, 2022

Real-life efficacy and safety of idelalisib in 55 double-refractory follicular lymphoma patients.

Real-life efficacy and safety of idelalisib in 55 double-refractory follicular lymphoma patients.

Journal: British journal of haematology
Published: June 02, 2022

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.

Journal: Blood
Published: March 23, 2022

Treatment options for acute myeloid leukemia patients aged <60 years.

Treatment options for acute myeloid leukemia patients aged <60 years.

Journal: Frontiers in oncology
Published: March 15, 2022

Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients.

Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients.

Journal: Frontiers in genetics
Published: December 26, 2021
Showing 1-12 of 73

Last Updated: 09/26/2026